Intellia Therapeutics
NTLA
₹569.34
Share price
-6.40%
Change (1 day)
-74.92%
Change (1 year)
Intellia Therapeutics (NTLA) - Cash on Hand
Cash on Hand as of December 2024 : ₹51.45 Billion
According to Intellia Therapeutics's latest financial reports the company has ₹51.45 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Intellia Therapeutics - Cash on Hand chart (from 2015 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2024-12-31 | ₹51.60 B | -32.05% |
| 2023-12-31 | ₹75.94 B | -23.05% |
| 2022-12-31 | ₹98.68 B | 77.1% |
| 2021-12-31 | ₹55.72 B | 27.55% |
| 2020-12-31 | ₹43.68 B | 119.02% |
| 2019-12-31 | ₹19.94 B | -9.16% |
| 2018-12-31 | ₹21.95 B | 0.95% |
| 2017-12-31 | ₹21.75 B | 17.23% |
| 2016-12-31 | ₹18.55 B | 268.3% |
| 2015-12-31 | ₹5.03 B | 707.48% |
| 2014-12-31 | ₹0.62 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 | ₹21.89 B | -57.45% | 🇺🇸 USA |